26 studies found for:    Benign Essential Blepharospasm
Show Display Options
Rank Status Study
1 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
2 Active, not recruiting Blepharospasm Patient Survey for Patients With Blepharospasm
Condition: Blepharospasm
Intervention: Other: No intervention- only one time survey
3 Completed
Has Results
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Acetyl-Hexapeptide Topical Treatment;   Drug: placebo
4 Completed Brain Changes in Blepharospasm
Condition: Blepharospasm
Intervention:
5 Active, not recruiting Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Biological: Xeomin®
6 Completed Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection
7 Completed Brain Stimulation to Treat Blepharospasm or Meige Syndrome
Conditions: Blepharospasm;   Focal Dystonia
Intervention: Procedure: repetitive transcranial magnetic stimulation (rTMS)
8 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
9 Completed
Has Results
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Biological: Botulinum Toxin Type A 900kDa;   Biological: Botulinum Toxin Type A 150kDa
10 Completed Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Condition: Essential Blepharospasm
Intervention: Drug: Botulinum Toxin Type A
11 Terminated Blepharospasm Short Interval
Condition: Blepharospasm
Intervention: Drug: NT 201
12 Completed
Has Results
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Drug: incobotulinumtoxinA (Xeomin);   Drug: Placebo
13 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Condition: Essential Blepharospasm
Interventions: Drug: Hugeltox;   Drug: Botulinum Toxin Type A(Botox®)
14 Not yet recruiting Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm
Condition: Pupillary Occlusion
Intervention:
15 Recruiting A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
16 Terminated Brain Changes in Blepharospasm
Conditions: Dystonia;   Focal Dystonia;   Cerebellar Disease
Intervention:
17 Not yet recruiting Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill
18 Completed Mexiletine for the Treatment of Focal Dystonia
Conditions: Blepharospasm;   Dystonia;   Spasm
Intervention: Drug: Mexiletine
19 Completed Movement Disorder Survey in East China
Conditions: Primary Dystonia;   Hemifacial Spasm
Intervention:
20 Completed Post Marketing Surveillance Study of Dysport
Conditions: Blepharospasm;   Hemifacial Spasm;   Cervical Dystonia;   Spasmodic Torticollis;   Cerebral Palsy;   Muscle Spasticity;   Cerebrovascular Accident;   Equinus Deformity;   Facial Hyperdynamic Lines
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results
Indicates status has not been verified in more than two years